 EDEN PRAIRIE, Minn., Aug. 23, 2021 PRNewswire -- NeuroOne Medical Technologies Corporation Nasdaq: NMTC; NeuroOne or the Company, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that it has executed an agreement with RBC Medical Innovations to develop and manufacture a proprietary radiofrequency RF generator for use with NeuroOnes combination recording and ablation electrode that is being designed to both record brain activity and ablate brain tissue using the same electrode. 